Jaris Computational Biology Centre has set a new standard in computational biology, by reshaping the scientific research ...

Schrödinger partners with Novartis for advanced computational drug discovery. Q3 revenue rose 10% in software, though total ...

The market growth is driven by technological progressions such as amalgamation with artificial intelligence and cloud ...

Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

Schrödinger Inc.'s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said it has entered a multi-year collaboration agreement with Swiss pharma ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...